List of Excipients in API naproxen sodium and pseudoephedrine hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing naproxen sodium and pseudoephedrine hydrochloride
Detailed excipient profiles for naproxen sodium and pseudoephedrine hydrochloride
Excipient focus: CELLULOSE, MICROCRYSTALLINE
naproxen sodium and pseudoephedrine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
naproxen sodium and pseudoephedrine hydrochloride drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
naproxen sodium and pseudoephedrine hydrochloride drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
naproxen sodium and pseudoephedrine hydrochloride drug variants containing HYPROMELLOSE
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
naproxen sodium and pseudoephedrine hydrochloride drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
naproxen sodium and pseudoephedrine hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
naproxen sodium and pseudoephedrine hydrochloride drug variants containing LACTOSE MONOHYDRATE
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
naproxen sodium and pseudoephedrine hydrochloride drug variants containing MAGNESIUM STEARATE
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
naproxen sodium and pseudoephedrine hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
naproxen sodium and pseudoephedrine hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
naproxen sodium and pseudoephedrine hydrochloride drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
naproxen sodium and pseudoephedrine hydrochloride drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
naproxen sodium and pseudoephedrine hydrochloride drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
naproxen sodium and pseudoephedrine hydrochloride drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
naproxen sodium and pseudoephedrine hydrochloride drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-816 |
| Aurohealth LLC | naproxen sodium and pseudoephedrine hydrochloride | 58602-832 |
| >Company | >Ingredient | >NDC |
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | naproxen sodium and pseudoephedrine hydrochloride | 50580-434 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
naproxen sodium and pseudoephedrine hydrochloride drug variants containing SILICON DIOXIDE
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
naproxen sodium and pseudoephedrine hydrochloride drug variants containing TALC
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
naproxen sodium and pseudoephedrine hydrochloride drug variants containing TITANIUM DIOXIDE
naproxen sodium and pseudoephedrine hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
